Mechanism of action of alpha-1-antitrypsin.
D000596:Amino Acids; D000813:Anilides; D001120:Arginine; D001224:Aspartic Acid / Q000032:analysis; D001565:Benzoates; D001665:Binding Sites; D001667:Binding, Competitive; D002800:Cholinesterase Inhibitors; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006037:Glyoxal; D006639:Histidine / Q000032:analysis; D007531:Isoflurophate; D007930:Leucine; D008239:Lysine; D009574:Nitro Compounds; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D010447:Peptide Hydrolases / Q000032:analysis; D011480:Protease Inhibitors; D012694:Serine / Q000032:analysis; D013329:Structure-Activity Relationship; D013381:Subtilisins / Q000037:antagonists & inhibitors; D013917:Thrombin / Q000037:antagonists & inhibitors; D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin
D000596:Amino Acids; D000813:Anilides; D001565:Benzoates; D002800:Cholinesterase Inhibitors; D009574:Nitro Compounds; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin; D007531:Isoflurophate; D001224:Aspartic Acid; D012694:Serine; D006639:Histidine; D006037:Glyoxal; D001120:Arginine; D010447:Peptide Hydrolases; D013381:Subtilisins; D002918:Chymotrypsin; D010196:Pancreatic Elastase; D013917:Thrombin; D005341:Fibrinolysin; D007930:Leucine; D008239:Lysine